BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus. (Q39586177)
Jump to navigation
Jump to search
scientific article published on December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus. |
scientific article published on December 2010 |
Statements
BRAF mutation-selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic-potentiated synergism with the mTOR inhibitor temsirolimus (English)
Joanna Xing
Barry Trink
Mingzhao Xing
1 December 2010
1 reference
1 reference
1 reference